...
机译:adadiomics使用Nivolumab预测患有PD-1封闭的先进非小细胞肺癌患者的存活
Osped Mare Integrated Dept Diagnost Radiol &
Radiotherapy Unit Radiat Oncol I-80147 Naples Italy;
Univ Hosp Siena Oncol Dept Unit Radiat Oncol I-53100 Siena Italy;
Univ Hosp Siena Oncol Dept Unit Radiat Oncol I-53100 Siena Italy;
Magna Graecia Univ Catanzaro AOU Mater Domini Integrated Area Med Oncol I-88100 Catanzaro Italy;
Univ Campania L Vanvitelli Dept Precis Med 7 Via Crecchio I-80138 Naples Italy;
Univ Hosp Siena Emergency Dept &
Diagnost Serv Unit Med Imaging I-53100 Siena Italy;
Grand Metropolitan HospitalBianchi Melacrino More Oncol Dept Unit Med Oncol I-89124 Reggio Di;
Grand Metropolitan HospitalBianchi Melacrino More Dept Diagnost Serv Unit Radiol I-89124 Reggio;
Grand Metropolitan HospitalBianchi Melacrino More Dept Diagnost Serv Unit Radiol I-89124 Reggio;
Osped Mare Integrated Dept Diagnost Radiol &
Radiotherapy Unit Radiat Oncol I-80147 Naples Italy;
IRCCS Ist Nazl Tumori Fdn G Pascale Epidemiol Unit I-80131 Naples Italy;
Magna Graecia Univ Catanzaro AOU Mater Domini Integrated Area Med Oncol I-88100 Catanzaro Italy;
Magna Graecia Univ Catanzaro AOU Mater Domini Integrated Area Med Oncol I-88100 Catanzaro Italy;
Magna Graecia Univ Catanzaro AOU Mater Domini Integrated Area Med Oncol I-88100 Catanzaro Italy;
Univ Campania L Vanvitelli Dept Precis Med 7 Via Crecchio I-80138 Naples Italy;
Univ Campania L Vanvitelli Dept Precis Med 7 Via Crecchio I-80138 Naples Italy;
Univ Campania L Vanvitelli Dept Precis Med 7 Via Crecchio I-80138 Naples Italy;
Univ Campania L Vanvitelli Dept Precis Med 7 Via Crecchio I-80138 Naples Italy;
Univ Hosp Siena Emergency Dept &
Diagnost Serv Unit Med Imaging I-53100 Siena Italy;
Univ Hosp Siena Oncol Dept Unit Radiat Oncol I-53100 Siena Italy;
Grand Metropolitan HospitalBianchi Melacrino More Oncol Dept Unit Med Oncol I-89124 Reggio Di;
non-small cell lung cancer; programmed cell death protein 1; radiomics; texture analysis; survival; nivolumab; immunology;
机译:adadiomics使用Nivolumab预测患有PD-1封闭的先进非小细胞肺癌患者的存活
机译:患者患者患者整体存活后生存临床影响,患者肺炎治疗为先进的非小细胞肺癌二线治疗
机译:辐射肺炎病史与间质肺病发作,患者预科晚期非小细胞肺癌患者进展生存
机译:基因表达谱预测晚期非小细胞肺癌患者的生存
机译:导致晚期非小细胞肺癌患者营养风险的症状:在晚期肺癌人群中进行营养筛查的重要性
机译:基线绝对淋巴细胞计数和ECOG性能评分与正在接受PD-1 / PD-L1阻断的晚期非小细胞肺癌的生存率相关
机译:循环T细胞受体曲目的表征提供了关于晚期非小细胞肺癌患者PD-1阻断后的临床结果的信息